Dr. Reddy’s launches India’s first neck and head cancer treatment drug

Share it

Dr Reddy’s had obtained exclusive rights to develop and commercialise Toripalimab in 21 countries including India, South Africa, Brazil and various countries in Latin America.

Leave a Comment

Your email address will not be published. Required fields are marked *